Navigation Links
New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients
Date:6/26/2010

urs prior to Welchol. Caution should be exercised when treating patients with a susceptibility to vitamin K or fat-soluble vitamin deficiencies.

Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, a history of major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders.

Welchol reduces gastrointestinal absorption of some drugs. Drugs with a known interaction with colesevelam (cyclosporine, glyburide, levothyroxine, and oral contraceptives [ethinyl estradiol, norethindrone]) should be administered at least 4 hours prior to Welchol. Drugs that have not been tested for interaction with colesevelam, especially those with a narrow therapeutic index, should also be administered at least 4 hours prior to Welchol. Alternatively, the physician should monitor drug levels of the co-administered drug.

To avoid esophageal distress, Welchol for Oral Suspension should not be taken in its dry form.

Due to tablet size, Welchol for Oral Suspension is recommended for, but not limited to, any patient who has difficulty swallowing tablets.

Phenylketonurics: Welchol for Oral Suspension contains 48 mg phenylalanine per 3.75 gram dose.

Adverse Reactions

In clinical trials, the adverse reactions observed in >/= 2% of patients, and more commonly with Welchol than placebo, regardless of investigator assessment of causality seen in:

  • Adults with Primary Hyperlipidemia were: constipation (11.0% vs 7.0%), dyspepsia (8.3% vs 3.5%), nausea (4.2% vs 3.9%), accidental injury (3.7% vs 2.7%), asthenia (3.6% vs 1.9%), pharyngitis (3.2% vs 1.9%), flu syndrome (3.2% vs 3.1%), rhinitis (
    '/>"/>

SOURCE Daiichi Sankyo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
2. ULORIC(R) (febuxostat) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout
3. Solos Endoscopy, Inc.s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
4. Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study
5. 5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
6. Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients
7. IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
8. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
9. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
10. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
11. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)...  University Hospitals (UH) Case Medical Center is ... area to implant a new miniaturized, wireless monitoring sensor to ... first and only FDA-approved heart failure monitoring device that has ... physicians to manage heart failure., The ... the pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:6/2/2015)... , June 2, 2015   PDI , ... today announced a series of corporate commitments designed ... to reduce the threat of antimicrobial-resistant microorganisms as ... Centers for Disease Control and Prevention (CDC) and ... to Combat Antibiotic-Resistant Bacteria. Along with ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has announced ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
Breaking Medicine Technology:UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3
... Bend Research Inc. ( www.bendres.com ), a leading independent ... has received a new U.S. patent covering a process ... pressure nozzles. The patent, which adds ... can be used to make solid amorphous dispersions with ...
... Inc. Magazine Tuesday ranked PercipEnz ... an exclusive ranking of the nation,s fastest-growing private ... at the most important segment of the economy—America,s ... 7-Eleven, Brooklyn Brewery, and Radio Flyer, maker of ...
Cached Medicine Technology:Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles 2PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 2PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 3PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 4
(Date:6/3/2015)... June 03, 2015 Fit Body Boot ... camp fitness program. The company helps thousands of individuals across ... encourage more people to hit the gym and get the ... tips for getting the most out any gym membership: , ... about committing to gym memberships is saying motivated and on ...
(Date:6/3/2015)... Veatch Consulting Services is excited to announce ... for business in April 2006, they have made it ... clients. Each and every year they have worked diligently ... to say that they are off to a great ... added this year is the Customer Review site veatchconsultingreviews.weebly.com. ...
(Date:6/3/2015)... evigilo, a world leader in delivering ... new branding by launching a new and enhanced content-centric ... identity: the logo depicting a sun-like image with a ... – To Know. To Act. In time. The color ... A global, borderless approach to alerting and delivering safety ...
(Date:6/2/2015)... 2015 The organic cotton market is ... an annual study conducted by Textile Exchange, an international ... The report, released today, encompasses extensive data about organic ... level and also takes the opportunity to celebrate those ... , The last several years have been complicated ...
(Date:6/2/2015)... 02, 2015 Aidan Booth And ... to public yesterday, and has since received rave ... product reviewer Tiffany Hendricks has weighed in with ... the course on her website HonestyFirstReviews.com. , "These ... Internet marketers looking to hone their business skills ...
Breaking Medicine News(10 mins):Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2
... The Society of Nuclear Medicine (SNM) commends the U.S. ... System Drugs Advisory Committee on its recent recommendation for ... agent, which is used in conjunction with positron emission ... the brain which may cause Alzheimer,s disease, is produced ...
... address the latest issues on the early detection of ... will host an international research consortium in Scottsdale, Ariz., ... Program, or I-ELCAP, is a lung cancer research organization ... 26 states and eight other countries whose mission ...
... Michigan Cardiovascular Center and the University of Pittsburgh have been ... devices for the large and growing group of Americans with ... Blood Institute and HeartWare International, a maker of left ventricular ... these devices that support the circulation of patients with failing ...
... MONDAY, Jan. 24 (HealthDay News) -- There,s a much greater ... they score just below a round number (such as 1200) than ... Researchers analyzed a set of SAT scores from 1994 to 2001 ... This indicates that students who got those scores were more likely ...
... Jan. 23 (HealthDay News) -- Sledding is one of ... certain safety precautions are needed in order to prevent ... recent year in which sledding injury data was available ... injuries treated at U.S. hospital emergency rooms, doctors, offices ...
... survive and thrive in its hiding spot within the human immune ... remains such a formidable foe after three decades of research ... it also offers scientists a new, unexpected way to try to ... of Rochester Medical Center and Emory University was published Dec. 10 ...
Cached Medicine News:Health News:SNM applauds FDA advisory committee recommendation for approval of Alzheimer's imaging agent 2Health News:Biodesign hosts international consortium on screening for lung cancer 2Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 2Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 3Health News:For Safe Sledding, Follow These Tips 2Health News:Unexpected find opens up new front in effort to stop HIV 2
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range...
Medicine Products: